GITNUX MARKETDATA
Browse Our Category
Medical Conditions Disorders
Latest update:
Carpal Tunnel Syndrome Statistics
Carpal Tunnel Syndrome affects 3 to 6 percent of adults and 9.2 percent in a global pooled meta-analysis, but the story shifts fast when you look at who is at highest risk and what it costs employers. You will see how women, manual labor, diabetes, pregnancy, and even winter peaks change incidence, alongside treatment outcomes like 90 to 95 percent success for open release and 500,000 surgeries a year in the US.
Breast Cancer In Men Statistics
A man’s breast cancer often starts quietly, with a painless lump under the nipple in 75% of cases, yet by diagnosis 40 to 60% have already reached axillary lymph nodes, making early detection and correct workup crucial. Get the latest U.S. scale and key biology, from 2,790 new male invasive cases per year, to estrogen receptor positivity in 90% and triple negative in 10 to 15%, plus how imaging and biopsy performance shape decisions.
Cancer Survival Rate Statistics
Breast cancer outcomes swing dramatically by how far it has spread, from a 99.3% 5 year relative survival for localized female breast cancer in the US to just 30.8% for distant disease diagnosed 2014 to 2020. Use these up to date survival benchmarks across countries, ages, and tumor types to understand what “stage” really means for prognosis, including aggressive subtypes and therapy effects.
Cord Blood Statistics
Private U.S. cord blood storage typically costs about $175 to $250 per year plus a one time $1,500 to $2,500 setup, while public banking is free for donors yet only 5 to 10 percent of collections get stored. You will also find transplant and science essentials alongside 2022 market context and the cell level facts that make cord blood different, from 2.5 to 5.0 billion total nucleated cells per unit to transfer trends like 1 in 2,700 U.S. families banking privately.
Endometriosis Infertility Statistics
From 40 to 60% spontaneous pregnancy within a year for people with endometriosis compared with 80% in fertile women, to IVF live birth rates that fall to 24% per cycle in mild disease and drop further to 18% when endometriomas exceed 3 cm, these 2025 style insights map exactly where fertility starts slipping and what raises the odds. You will also find the practical contrasts that matter, like frozen embryo transfer reaching 35% live birth versus 28% with fresh, and how targeted steps such as GnRH agonist pretreatment, embryo selection tools, or endometrioma focused care can shift outcomes by double digit margins.
Anemia Statistics
Anemia still affects 1.92 billion people, and the page breaks down why the biggest drivers are not interchangeable. Iron deficiency explains 50% worldwide, yet in specific settings the picture flips fast, from 52.9% anemia in preschool children in sub-Saharan Africa and 50 to 90% prevalence in CKD stage 5 to pregnancy raising iron needs by about 1000 mg and putting 40% at risk without supplementation.
Gerd Statistics
GERD is common across adults, but the real shock is what chronic reflux can do, from esophageal adenocarcinoma risk rising 30 to 40 times to Barrett’s metaplasia progressing to dysplasia in 30 percent of cases, and a 50 percent quality of life drop when symptoms go untreated. This page pairs the prevalence, alarm symptoms, and complication rates with current treatment outcomes like 92 percent healing with esomeprazole 40 mg and why refractory GERD affects 30 percent of PPI nonresponders.
Breast Cancer Diagnosis Statistics
Screening can spot tumors early yet also triggers a lot of false alarms, with 49% false positives over 10 years and interval cancers accounting for 20 to 30% of all cases, while 94% of screen detected cancers are invasive stage I or II and 5 year survival is 99.3% for localized disease. This 2025 update brings the tradeoffs into focus with triple assessment accuracy of 99.7% and mammography recall having just a 4 to 5% positive predictive value, so you can understand what each test means and why stage shifts after early detection matter.
Sudden Death Syndrome Statistics
From ventricular arrhythmias driving 80% of SADS linked to ion channel defects, to Brugada syndrome at 5 to 10% and myocarditis at 8 to 12%, this page connects what goes wrong biologically with who is most at risk, including an average death age of 23 years and a 70% rate of ventricular fibrillation as the terminal rhythm. It also pinpoints the often missed catalysts such as autonomic imbalance and hidden structural disease so you can see why prevention and detection choices can change outcomes.
Sleep Apnea Statistics
Untreated obstructive sleep apnea is not just a sleep problem it can triple coronary heart disease risk and raise all cause mortality to 3 times higher in severe cases, while 1 in 4 adults aged 30 to 70 in the US are affected. This page pulls together the surprising cascade from stroke and atrial fibrillation to diabetes, driving crashes, and pregnancy complications, so you can see what is really at stake and why treatment matters.
Chronic Disease Statistics
Chronic diseases drain the US healthcare system, with 90% of spending tied to conditions that also drive staggering personal and economic tolls, including $4.5 trillion in costs in 2022 and Alzheimer’s projected to reach $1 trillion by 2050. You will see how NCDs kill 41 million people each year and how targeted prevention such as quitting smoking, blood pressure control, and diabetes management can cut risk dramatically across the most common diseases.
Diabetes Mellitus Statistics
Diabetes is already costing the world USD 966 billion in 2021 and global prevalence is projected to climb to 643 million adults by 2030, yet the real shock is the imbalance between burden and response, including a 45.1% global undiagnosed rate. If you want to see how that gap turns into deaths, disability, and healthcare pressure, this page connects costs like US diabetes spending of USD 412.9 billion annually and diabetes DALYs of 79 million globally to the symptoms, complications, and prevention evidence that shape policy and care.
Glioblastoma Survival Statistics
Age and molecular markers reshape glioblastoma survival fast, from 20 to 30 months median overall survival in patients under 40 to just 3 to 4 months in those over 75 even with treatment. See the most current contrasts and trial benchmarks, including 20.9 months median overall survival with TTFields plus temozolomide, the 14.6 versus 12.1 month Stupp comparison for standard chemoradiation, and why MGMT methylation can turn grim odds into 21.7 months median overall survival.
Color Blind Statistics
Most color vision differences trace back to OPN1LW and OPN1MW mutations on the X chromosome, with 99.9% of cases tied to these genes, yet the outcomes vary widely due to X inactivation and recombination hotspots that drive 70% of mild defects. See how rare conditions like tritanopia and achromatopsia stack up against everyday impacts, plus what current testing and emerging gene and cell approaches could mean for real restoration.
Insomnia Statistics
CBT I posts a 70 to 80% remission rate at 6 months, yet objective sleep tools like polysomnography confirm insomnia in only 20 to 30% of cases, making diagnosis and treatment feel mysteriously out of sync. The page tracks what actually moves the needle, from CBT I and light therapy to melatonin and sleep restriction, alongside the real life costs and risk jumps tied to chronic insomnia.
Pku Statistics
From 99.7 percent sensitivity and a false positive rate under 0.05 percent to confirmatory classic PKU requiring plasma Phe above 20 mg/dL, this PKU statistics page connects screening thresholds and genetic testing accuracy in one place. It also pulls the real-world stakes into view, from Turkey’s high incidence of 1 in 2,605 births to the 95 percent chance of preventing brain damage when diet starts within 7 to 10 days, showing exactly why timing and testing choices matter.
Diabetic Foot Ulcer Statistics
At diagnosis, Wagner grade 3+ ulcers appear in 25% of people while the mean ulcer is already 2.5 cm² and infection is present in 50 to 60% of diabetic foot ulcers, a combination that helps explain why osteomyelitis shows up in 20% of chronic cases. This page connects those early warning signals to outcomes like 14 to 24% leading to amputation and a 30-day readmission rate of 30%, so clinicians can spot risk sooner and act faster.
Eye Cancer Statistics
Uveal melanoma hits hardest after 60, yet blue or fair features, BAP1 germline mutations, and certain occupations can swing lifetime risk dramatically, from 50 cases per million ages 60 to 70 to 1 in 14,000 for whites overall. Want the bigger picture of risk, diagnosis, and outcomes across the eye. Expect eye cancers to look wildly different by age, genetics, and immune status, with key survival contrasts and rare but high stakes syndromes like xeroderma pigmentosum and RB1 related retinoblastoma.